title: Reconstitution of T-cell repertoire after autologous stem cell transplantation: influence of CD34 selection and cytomegalovirus infection.
abstract: The period of immunodeficiency following autologous hematopoietic stem cell transplantation is characterized by transient expansions of CD8+CD45RO+CD57+ T lymphocytes, displaying markers of an activated phenotype. Most evidence suggests that this early reconstitution results from proliferation of mature T cells that have survived conditioning or were transferred with the graft. Although homeostatic mechanisms are thought to act in maintaining total T-cell numbers, the degree to which antigen-driven expansions contribute and the nature of the stimulating antigens remain unclear. CD34 selection of stem cell grafts reduces the available T-cell pool, potentially delaying immune reconstitution and resulting in increased infective complications. In the allogeneic transplantation setting, lymphopenia has been associated with cytomegalovirus (CMV) infection risk and, if persistent, with adverse outcome. We prospectively studied patients undergoing CD34-selected (n = 13) or unselected (n = 13) autologous hematopoeitic stem cell transplantation for immune reconstitution and CMV infection. No significant differences were demonstrated between graft types with respect to lymphocyte subset recovery, T-cell receptor beta-chain variable region spectratype diversity, or CMV DNA detection rates (45% versus 40%). CMV infection was associated with a trend toward higher rather than lower CD8+ counts at 6 weeks posttransplantation (P =.08) that became significant by 3 months (P=.007), and that was associated with decreased T-cell receptor beta-chain variable region spectratype diversity (P =.01). CMV-specific HLA-tetramer analysis demonstrated transient expansions with CDR3 lengths corresponding to those of some of the major posttransplantation T-cell expansions demonstrated by spectratype analysis suggesting that CMV-specific T cells contribute to the pattern of immune reconstitution.
authors.affiliation: Department of Haematology, University College London, London, United Kingdom. kpeggs@hotmail.com
authors.forename: Karl S
authors.initials: KS
authors.lastname: Peggs
authors.forename: Stephanie
authors.initials: S
authors.lastname: Verfuerth
authors.forename: Arnold
authors.initials: A
authors.lastname: Pizzey
authors.forename: Naeem
authors.initials: N
authors.lastname: Khan
authors.forename: Paul
authors.initials: P
authors.lastname: Moss
authors.forename: Anthony H
authors.initials: AH
authors.lastname: Goldstone
authors.forename: Kwee
authors.initials: K
authors.lastname: Yong
authors.forename: Stephen
authors.initials: S
authors.lastname: Mackinnon
mesh_terms: D000328:Adult; D018952:Antigens, CD34; D022801:Complementarity Determining Regions; D003586:Cytomegalovirus Infections / Q000175:diagnosis / Q000276:immunology; D004279:DNA, Viral / Q000097:blood; D005260:Female; D006085:Graft Survival; D006410:Hematopoiesis; D006801:Humans; D008213:Lymphocyte Activation / Q000276:immunology; D016131:Lymphocyte Subsets; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000150:complications / Q000628:therapy*; D036102:Peripheral Blood Stem Cell Transplantation / Q000379:methods* / Q000592:standards; D011446:Prospective Studies; D016693:Receptors, Antigen, T-Cell, alpha-beta; D013601:T-Lymphocytes / Q000166:cytology / Q000276:immunology*; D014182:Transplantation, Autologous
chemical_list: D018952:Antigens, CD34; D022801:Complementarity Determining Regions; D004279:DNA, Viral; D016693:Receptors, Antigen, T-Cell, alpha-beta